Fresenius SE & Co. KGaA FRE.DE Stock
Fresenius SE & Co. KGaA Price Chart
Fresenius SE & Co. KGaA FRE.DE Financial and Trading Overview
| Fresenius SE & Co. KGaA stock price | 44.52 EUR |
| Previous Close | 44.25 EUR |
| Open | 44.4 EUR |
| Bid | 44.33 EUR x N/A |
| Ask | 44.36 EUR x N/A |
| Day's Range | 43.95 - 44.62 EUR |
| 52 Week Range | 35.11 - 52.96 EUR |
| Volume | 600.02K EUR |
| Avg. Volume | 1.3M EUR |
| Market Cap | 24.95B EUR |
| Beta (5Y Monthly) | 0.822 |
| PE Ratio (TTM) | 16.52985 |
| EPS (TTM) | 2.68 EUR |
| Forward Dividend & Yield | 1.05 (2.36%) |
| Ex-Dividend Date | May 25, 2026 |
| 1y Target Est | 54.51 EUR |
FRE.DE Valuation Measures
| Enterprise Value | 35.45B EUR |
| Trailing P/E | 16.52985 |
| Forward P/E | 11.332009 |
| PEG Ratio (5 yr expected) | 0.81 |
| Price/Sales (ttm) | 1.0855045 |
| Price/Book (mrq) | 1.2612458 |
| Enterprise Value/Revenue | 1.542 |
| Enterprise Value/EBITDA | 11.687 |
Trading Information
Fresenius SE & Co. KGaA Stock Price History
| Beta (5Y Monthly) | 0.822 |
| 52-Week Change | 4.60% |
| S&P500 52-Week Change | 16.36% |
| 52 Week High | 52.96 EUR |
| 52 Week Low | 35.11 EUR |
| 50-Day Moving Average | 39.93 EUR |
| 200-Day Moving Average | 45.15 EUR |
FRE.DE Share Statistics
| Avg. Volume (3 month) | 1.3M EUR |
| Avg. Daily Volume (10-Days) | 1.03M EUR |
| Shares Outstanding | 563.24M |
| Float | 410.56M |
| Short Ratio | N/A |
| % Held by Insiders | 27.01% |
| % Held by Institutions | 46.01% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.05 |
| Trailing Annual Dividend Yield | 2.37% |
| 5 Year Average Dividend Yield | 114.99% |
| Payout Ratio | 0.3731 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.39% |
| Operating Margin (ttm) | 10.22% |
| Gross Margin | 25.29% |
| EBITDA Margin | 13.19% |
Management Effectiveness
| Return on Assets (ttm) | 3.32% |
| Return on Equity (ttm) | 7.78% |
Income Statement
| Revenue (ttm) | 22.99B EUR |
| Revenue Per Share (ttm) | 40.81 EUR |
| Quarterly Revenue Growth (yoy) | 2.00% |
| Gross Profit (ttm) | 5.81B EUR |
| EBITDA | 3.03B EUR |
| Net Income Avi to Common (ttm) | 1.51B EUR |
| Diluted EPS (ttm) | 2.68 |
| Quarterly Earnings Growth (yoy) | 90.00% |
Balance Sheet
| Total Cash (mrq) | 2.06B EUR |
| Total Cash Per Share (mrq) | 3.66 EUR |
| Total Debt (mrq) | 11.91B EUR |
| Total Debt/Equity (mrq) | 58.17 EUR |
| Current Ratio (mrq) | 1.265 |
| Book Value Per Share (mrq) | 35.124 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.91B EUR |
| Levered Free Cash Flow (ttm) | 1.8B EUR |
Profile of Fresenius SE & Co. KGaA
| Country | Germany |
| State | N/A |
| City | Bad Homburg vor der Höhe |
| Address | Else-Kröner-Straße 1 |
| ZIP | 61352 |
| Phone | 49 6172 6080 |
| Website | https://www.fresenius.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 177783 |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Q&A For Fresenius SE & Co. KGaA Stock
What is a current FRE.DE stock price?
Fresenius SE & Co. KGaA FRE.DE stock price today per share is 44.52 EUR.
How to purchase Fresenius SE & Co. KGaA stock?
You can buy FRE.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fresenius SE & Co. KGaA?
The stock symbol or ticker of Fresenius SE & Co. KGaA is FRE.DE.
Which industry does the Fresenius SE & Co. KGaA company belong to?
The Fresenius SE & Co. KGaA industry is Medical Care Facilities.
How many shares does Fresenius SE & Co. KGaA have in circulation?
The max supply of Fresenius SE & Co. KGaA shares is 563.24M.
What is Fresenius SE & Co. KGaA Price to Earnings Ratio (PE Ratio)?
Fresenius SE & Co. KGaA PE Ratio is 16.61194000 now.
What was Fresenius SE & Co. KGaA earnings per share over the trailing 12 months (TTM)?
Fresenius SE & Co. KGaA EPS is 2.68 EUR over the trailing 12 months.
Which sector does the Fresenius SE & Co. KGaA company belong to?
The Fresenius SE & Co. KGaA sector is Healthcare.
Fresenius SE & Co. KGaA FRE.DE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Prime All Share P
PRIME
DE
|
9844.09 EUR 11363.37 USD |
-0.03
|
— — | 9803.01 EUR 11315.95 USD | 9888.12 EUR 11414.2 USD | — - | — — |
US Tech Developed Select Leaders
NQDMSLC
US
|
1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
|
DAX P
GDAXI
DE
|
25460.48 EUR 29389.91 USD |
-0.01
|
— — | 25336.39 EUR 29246.67 USD | 25571.45 EUR 29518.01 USD | — - | — — |
|
DAXsector Pharma & Healthcare P
CXPPX
DE
|
4142.09 EUR 4781.36 USD |
+1.41
|
— — | 4074.95 EUR 4703.86 USD | 4142.09 EUR 4781.36 USD | — - | — — |
EURO STOXX 50 I
STOXX50E
CH
|
6248.84 EUR 7213.25 USD |
-0.65
|
— — | — — | — — | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
|
DAX K
GDAXIP
DE
|
9293.11 EUR 10727.36 USD |
-0.01
|
— — | 9247.82 EUR 10675.08 USD | 9333.62 EUR 10774.12 USD | — - | — — |
|
DAXGLOBAL RUSSIA PR GBP
GDAXHI
DE
|
0.04 GBP 0.05 USD |
-99.89
|
— — | 0.04 GBP 0.05 USD | 0.04 GBP 0.05 USD | — - | — — |
|
DAXsector Pharma & Healthcare K
CXKPX
DE
|
2129.23 EUR 2457.84 USD |
+1.41
|
— — | 2129.23 EUR 2457.84 USD | 2129.23 EUR 2457.84 USD | — - | — — |
- {{ link.label }} {{link}}